U.S. Markets close in 4 hrs 51 mins

MiMedx Group, Inc. (MDXG)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
15.37-0.01 (-0.07%)
As of 11:08AM EDT. Market open.
People also watch
OSIRNEOHALOMACKTGTX
  • If only I had sold when it hit $15 per share.
  • Awesome love this
  • Heyter - how do you explain the company being the first one to say regenerative and then back it up with data?
  • Hey Ozark....how is that pea brain of yours working?? Still polishing that crack due diligence of yours? LMFAO.

    ozark580
    4 months ago

    MiMedx is trying desperately to hang onto the $8s, but share buybacks are only illusionary. MiMedx should instead try manufacturing a product that actually works, maybe better than 18.2% of the time. But, they might need to use a freezer if they did!

    ----------

    Ah, Ozark, hello? Anybody home? Hello?

    And then there is this brainfart from sissy boy Ozark:

    ozark580
    4 months ago

    John Boy, Pete must be getting desperate. MiMedx added another $10 million more to their stock buyback plan. It must be getting tough meeting earnings expectations and MiMedx apparently finds it necessary to artificially prop up their share price.

    ----------------

    Take a guess on the profit so far sissy Ozark.

    Oh, there’s more from the blabber mouth tinker…

    ozark580
    4 months ago

    The "ding-a-ling" crew; Buffy Boy, Frozen, Wendy, Scotty Boy, Johnny Boy...I don't hear any laughter. Maybe you'll start laughing again if it hits the $6s, lets just wait and see???

    ---------

    LAUGHING at you ozzie girl…..the depth of your ignorance is truly bottomless.

    Bbbbwwawwwwhhhhhhaaaahaaaaaahhhahahahahahahahahahahaha
  • Scientific And Clinical Review Confirms Potential Of MiMedx DHACM Allografts For Regenerative Applications In Orthopedics

    dHACM Allografts Retain Growth Factors And Bioactive Proteins Shown To Regulate Activity Of Cell Types, Including Stem Cells, That Are Critical To Orthopedic Repair Of Injured And Diseased Tissue

    -----------------------------------

    MiMedx Amniofix Data Showing Colorectal Anastomotic Leak Rate Reduction Presented At ASCRS Meeting

    The company has announced the presentation of new clinical data at the American Society of Colon and Rectal Surgeons 2017 Annual Scientific and Tripartite Meeting ("2017 ASCRS Annual Scientific Meeting"), showing that the use of AmnioFix, MiMedx's surgical dehydrated Human Amnion/Chorion Membrane (dHACM), around colorectal anastomoses can reduce post-operative leak rates.
  • yes yes yes yes yes yes yes yes
  • Timeout! Did they publish what I think they published?!!! Regenerative
  • Get A HAS LEFT THE BUILDING
  • hey I bet get a clue lives in a trailer & is 80 years old
    I guess the poor soul has nothing to do but post
  • Very silent about the Federal indictments at Deerfield Capital, eh halloweencandyASS?
  • It's nice, if not comical, having idiot posters like Get A Clue, Ozark (and others) post their baseless and ignoratnt remarks here. It's proof that MDXG is the leader and no one can catch them.

    Big Pharma has taken notice. I think mid- to high $20s is now very probable,
  • Hi idiot, mdxg is down .02 today. Just wondering if I should push the panic button?
  • Betting on MDXG and BLGO....big upsides
  • I see the light! Get A - I think I will cut bait and run. Your incessant badgering about the 1.2 billion of misstated revenue has caused me to investigate further. Mdxg is a fraud. I can't get my tech in time to sell today. If the markets are open tomorrow I am selling the entire lot of mdxg.
  • Stock is down today. Prediction: dbag will surface and tell us how mdxg is a terrible company and we are all losers and our 250% profit is minimal...
  • Get A - I need some advice as the stock gets back to $15. I lost 2 weeks off of my investment life. What should I do?
  • Is Joseph Munda at First Analysis representing some of the short sellers, or his firm on the wrong end of some bad option contracts? First Analysis should change their name to Last Analysis. His most recent recommendation was certainly a very poor analysis.
  • In the short-term MDXG does not seem to be like a good trade. if you guys have questions you should ask awesome.stock.s. They often respond to my emails which is helpful.
  • What is annual usage/frequency of a cortisone injections?
  • Hi Eric! MDXG is sweet! Profit, pipeline, and product. And there's a total dbag, hater on this board. He has nothing concrete or factual to share. He goes by get a life. Stock will be at $20 end of year.